SCHEMBL28296288

SCHEMBL28296288

FC(F)(F)c1ccnc([CH]Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.52
NOS2 P35228 1/20 0.52
ADRB1 P08588 1/20 0.40
MAPK1 P28482 2/20 0.37
ADRB2 P07550 1/20 0.36
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
AURKA O14965 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
KIF11 P52732 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29357398 0.80 NOS3 (0.52) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL2082377 0.80 NOS3 (0.52) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL25403401 0.80 NOS3 (0.52) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL5213660 0.80 NOS3 (0.52) NOS3NOS2ADRB1MAPK1ADRB2
Hydrochloric Acid SCHEMBL29085458 0.78 NOS3 (0.50) NOS3NOS2ADRB1MAPK1ADRB2
Bromide SCHEMBL29085463 0.78 NOS3 (0.50) NOS3NOS2ADRB1MAPK1ADRB2
Hydrochloric Acid SCHEMBL29085462 0.78 NOS3 (0.50) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL1988876 0.77 NOS3 (0.48) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL18534884 0.76 NOS3 (0.47) NOS3NOS2ADRB1MAPK1ADRB2
SCHEMBL21645919 0.76 NOS3 (0.47) NOS3NOS2ADRB1MAPK1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843891-A Oxadiazolopyridine derivatives as ghrelin O-acyltransferase (GOAT) inhibitors 勃林格殷格翰国际有限公司 2019-06-04 CN disclosed